The Venous Center

Filter Your Results

 

News

 

Twelve-Month NEAT Results Published for TVA Medical's everlinQ endoAVF System

June 15, 2017 -- TVA Medical, Inc. announced that 12-month results from the Novel Endovascular Access Trial (NEAT) were published online by Charmaine E. Lok, MD, et al in…

Ekos Therapy for Postthrombotic Syndrome Evaluated in ACCESS PTS Study

June 16, 2017 -- BTG International announced that results of the ACCESS PTS trial were presented at the Society for Vascular Medicine's 28th annual scientific session…

Study Evaluates Endovenous Thermal Ablation for Chronic Venous Insufficiency

June 15, 2017 -- The Society for Vascular Surgery (SVS) announced the publication of new evidence that suggests that minimally invasive methods to ablate superficial venous re…

Paclitaxel Versus Plain Balloon Angioplasty Compared in Treatment of Symptomatic Central Venous Stenosis in Dialysis Access

June 14, 2017 -- Results from a randomized controlled trial comparing the clinically assessed intervention-free period (IFP) of paclitaxel-coated balloon (PCB) angioplast…

Medtronic Commences IDE Study of In.Pact AV Access DCB in Patients With End-Stage Renal Disease

May 24, 2017 -- Medtronic announced that the first patient has been enrolled in a study of the company's In.Pact AV Access drug-coated balloon (DCB) under a US F…

OPTALYSE PE Study Evaluates Shorter, Lower-Dose Thrombolysis With Ekos Therapy

May 22, 2017 -- BTG International announced that the results of the OPTALYSE PE trial showed that pulmonary embolism (PE) can be treated effectively with the company's Eko…

FDA Approves Feasibility Study of LimFlow's PDVA System to Treat End-Stage CLI Patients

April 26, 2017 -- LimFlow SA announced that the US Food and Drug Administration has approved the company's investigational device exemption for a feasibilit…

Three-Year VeClose Data and 1-Year WAVES Data Presented for Medtronic's VenaSeal Closure System

April 25, 2017 -- Medtronic announced 3-year outcomes from the VeClose United States pivotal clinical trial and 1-year data from the WAVES study, which were presented by Kathl…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.